| http://www.w3.org/ns/prov#value | - The paclitaxel extended stability injection of the present invention is a modified formulation of the commercial product Taxol??? (Mead Johnson Oncology, Div. Bristol-Myers Squibb) designed to increase the utility time of paclitaxel in infusion solutions before the drug begins to precipitate (see, for example, Formulas I and II in Table I).
|
